Prosecution Insights
Last updated: November 04, 2026
Application No. 18/670,649

ORTHOPEDIC SPINAL SURGICAL IMPLANT AND METHOD OF USE

Final Rejection §103§112
Filed
May 21, 2024
Priority
Apr 19, 2023 — provisional 63/460,330 +1 more
Examiner
HARVEY, JULIANNA NANCY
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Futurespine Inc.
OA Round
2 (Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
4m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
966 granted / 1242 resolved
+7.8% vs TC avg
Strong +19% interview lift
Without
With
+19.1%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
43 currently pending
Career history
1299
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
38.8%
-1.2% vs TC avg
§102
26.0%
-14.0% vs TC avg
§112
23.9%
-16.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1242 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 5 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Due to the amendment to claim 1 reciting the step of “withdrawing the cannula from the respective vertebra,” claim 5 is not further limiting. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-7 are rejected under 35 U.S.C. 103 as being unpatentable over Lee et al. (US 2012/0143335 A1). Claim 1. Lee discloses a method for fusing adjacent vertebra (vertebral bodies 126 and 130; note that vertebral bodies 126 and 130 are adjacent after the removal of vertebral body 134), the method comprising steps of: inserting an implantable vertebral interbody device (device 50) between the adjacent vertebrae, the implantable vertebral interbody device comprising: a body (see Fig. 20 inset) having an upper vertebral contacting surface (see Fig. 20 inset), a lower vertebral contacting surface (see Fig. 20 inset), and a sidewall (see Fig. 20 inset) extending between the upper vertebral contacting surface and the lower vertebral contacting surface, a port (see Fig. 20 inset) through the sidewall, at least one orifice (see Fig. 20 inset) passing through at least one of the upper vertebral contacting surface or the lower vertebral contacting surface; and a moveable cannula (hollowing instrument 276; see para. 0067, which states that hollowing instrument 276 is passed through device 50, indicating that hollowing instrument 276 is moveable) passing through the port and at least one orifice; deploying the cannula by applying a force to a first, force receiving end (see Fig. 20 inset) of the cannula, wherein the force inserts a second, engaging end (see Fig. 20 inset) of the cannula into a facing surface (surface of vertebral body 130 in contact with the upper vertebral contacting surface of the body as shown in Fig. 20) of a respective vertebra of the adjacent vertebrae, wherein at least a portion of the cannula is positioned within the respective vertebra (see para. 0067, which states that hollowing instrument 276 is passed through device 50 to hollow out vertebral body 130); and dispensing a stabilization material through the cannula (see para. 0067, which states that the cavity in vertebral body 130 receives bone cement via sleeve 280) (Fig. 20; para. 0067). [AltContent: textbox (Upper Vertebral Contacting Surface)][AltContent: textbox (Lower Vertebral Contacting Surface)][AltContent: textbox (Orifice)][AltContent: textbox (Port)][AltContent: textbox (Sidewall)][AltContent: textbox (Body)][AltContent: textbox (Engaging End)][AltContent: textbox (Force Receiving End)] Claim 2. Lee discloses wherein the step of dispensing the stabilization material through the cannula dispenses the stabilization material into the respective vertebra (see para. 0067, which states that the cavity in vertebral body 130 receives bone cement via sleeve 280) (Fig. 20; para. 0067). Claim 3. Lee discloses wherein the step of dispensing the stabilization material through the cannula dispenses the stabilization material into the respective vertebra (see para. 0067, which states that the cavity in vertebral body 130 receives bone cement), wherein the stabilization material stabilizes the respective vertebra in an area proximate the respective surface of the implantable vertebral interbody device (see Fig. 20) (Fig. 20; para. 0067). Claim 4. Lee discloses wherein the step of dispensing the stabilization material through the cannula is accomplished by using bone cement as the stabilization material (see para. 0067, which states that the cavity in vertebral body 130 receives bone cement) (Fig. 20; para. 0067). Claim 6. Lee discloses a step of passing the cannula through the port through the sidewall (see Fig. 20) (Fig. 20; para. 0067). Claim 7. Lee discloses wherein the step of deploying the cannula by applying a force to a first, force receiving end of the cannula is accomplished by utilizing a mechanically applied force (see para. 0067, which states that hollowing instrument includes semi-rigid articulating arm 284 to create a cavity in vertebral body 130) (Fig. 20; para. 0067). Lee fails to disclose a step of withdrawing the cannula from the respective vertebra, wherein a portion of the stabilization material remains within the at least one orifice continuous with a mass of the stabilization material in the respective vertebra to mechanically couple the implantable vertebral interbody device to the respective vertebra (claim 1) and withdrawing the cannula from the vertebra (claim 5). However, Lee teaches that the cannula is moveable relative to the implantable vertebral interbody device and that the cannula includes sharp tip (cutting tip 288) (see para. 0076) (Fig. 20; para. 0067). Lee also teaches an alternate embodiment of a method for fusing adjacent vertebrae, the method comprising the steps of: inserting an implantable vertebral interbody device (device 50) between the adjacent vertebrae, the implantable vertebral interbody device comprising: a port (opening at location of flexible trocar 166 as shown in Fig. 8) through the sidewall, at least one orifice (opening where device 50 is in contact with vertebral body 130 as shown in Figs. 8-10) passing through an upper vertebral contacting surface (surface in contact with vertebral body 130 as shown in Figs. 8-10) of the body; dispensing a stabilization material (PMMA 170) through the port and orifice (see para. 0054, which states that the cavity in vertebral body 130 receives PMMA 170; see also Figs. 8-10), wherein a portion of the stabilization material remains within the orifice continuous with a mass of the stabilization material in the respective vertebra to mechanically couple the implantable vertebral interbody device to the respective vertebra (see Fig. 10) to provide for stabilization of the vertebrae (see paras. 0003-0004) (Fig. 8-10; paras. 0003-0004 and 0054). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Lee by withdrawing the cannula from the respective vertebra (claim 1) and withdrawing the cannula from the vertebra (claim 5) in order to avoid leaving a sharp surgical instrument that is not in a fixed position relative to the body of the device within the patient after the completion of the surgical procedure. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Lee such that a portion of the stabilization material remains within the at least one orifice continuous with a mass of the stabilization material in the respective vertebra to mechanically couple the implantable vertebral interbody device to the respective vertebra (claim 1), as suggested by an alternate embodiment of Lee, to provide for stabilization of the vertebrae. Claim 9 is rejected under 35 U.S.C. 103 as being unpatentable over Lee et al. (US 2012/0143335 A1) as applied to claim 1 above, and further in view of Hoffman (US 2010/0145454 A1). Claim 9. Lee discloses wherein the second, engaging end of the cannula further comprises a cutting surface (see para. 0067, which states that tip 288 comprises a cutting surface) and the method further comprising a step of using the cutting surface of the cannula to penetrate the respective vertebra of the adjacent vertebrae (see para. 0067) (Fig. 20; para. 0067). Lee Fails to disclose wherein the cutting surface is a pointed shape (claim 9). Hoffman teaches that a cutting surface (tip at distal end 72) is a sharpened or pointed tip (see para. 0042) (Fig. 8; para. 0042). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to further modify the method of Lee such that the cutting surface is a pointed shape (claim 9), as suggested by Hoffman, as it is well-known in the art that a pointed shape is appropriate for a cutting surface. Claims 21, 22, and 24 are rejected under 35 U.S.C. 103 as being unpatentable over Lee et al. (US 2012/0143335 A1). Claim 21. Lee discloses a method, comprising: inserting an implantable vertebral interbody device (device 50) between adjacent vertebrae (vertebral bodies 126 and 130; note that vertebral bodies 126 and 130 are adjacent after the removal of vertebral body 134), the implantable vertebral interbody device including an upper vertebral contacting member (see Fig. 20 inset), a lower vertebral contacting member (see Fig. 20 inset), at least one orifice (see Fig. 20 inset) passing through at least one of the upper vertebral contacting member or the lower vertebral contacting member, and a sidewall (see Fig. 20 inset) positioned between the upper vertebral contacting member and the lower vertebral contacting member, wherein the sidewall has an opening (see Fig. 20 inset); moving a cannula (hollowing instrument 276; see para. 0067, which states that hollowing instrument 276 is passed through device 50) through the opening and the at least one orifice such that a distal portion (see Fig. 20 inset) of the cannula is positioned within one of the vertebrae, wherein at least a portion of the cannula is positioned within one of the vertebrae (see para. 0067, which states that hollowing instrument 276 is passed through device 50 to hollow out vertebral body 130); and dispensing a stabilization material through the cannula, which is positioned in the opening and the at least one orifice, and into the one of the vertebrae (see para. 0067, which states that the cavity in vertebral body 130 receives bone cement via sleeve 280) (Fig. 20; para. 0067). [AltContent: textbox (Upper Vertebral Contacting Member)][AltContent: textbox (Lower Vertebral Contacting Member)][AltContent: textbox (Orifice)][AltContent: textbox (Opening)][AltContent: textbox (Sidewall)][AltContent: textbox (Distal Portion)][AltContent: textbox (Proximal End)][AltContent: textbox (Distal End)] Claim 22. Lee discloses wherein the at least one orifice is positioned between a distal end (see Fig. 20 inset) of the implantable vertebral interbody device and a proximal end (see Fig. 20 inset) of the implantable vertebral interbody device while dispensing the stabilization material (see Fig. 20), and wherein an outer periphery (defined by the area with the largest diameter, which would be adjacent the opening as shown in Fig. 20) of the implantable vertebral interbody device is positioned inward of a periphery of a disc space between the adjacent vertebrae (see Fig. 20) (Fig. 20; para. 0067). Claim 24. Lee discloses wherein the implantable vertebral interbody device is a cage (see Fig. 20), and the sidewall is connected to the upper vertebral contacting member and the lower vertebral contacting member (see Fig. 20) (Fig. 20; para. 0067). Lee fails to disclose a step of withdrawing the cannula from the one of the vertebrae, wherein a portion of the stabilization material remains within the at least one orifice continuous with a mass of the stabilization material in the one of the vertebrae to mechanically couple the implantable vertebral interbody device to the one of the vertebrae (claim 21). However, Lee teaches that the cannula is moveable relative to the implantable vertebral interbody device and that the cannula includes sharp tip (cutting tip 288) (see para. 0076) (Fig. 20; para. 0067). Lee also teaches an alternate embodiment of a method for fusing adjacent vertebrae, the method comprising the steps of: inserting an implantable vertebral interbody device (device 50) between the adjacent vertebrae, the implantable vertebral interbody device comprising: an opening (opening at location of flexible trocar 166 as shown in Fig. 8) through the sidewall, at least one orifice (opening where device 50 is in contact with vertebral body 130 as shown in Figs. 8-10) passing through an upper vertebral contacting member (surface in contact with vertebral body 130 as shown in Figs. 8-10) of the body; dispensing a stabilization material (PMMA 170) through the opening and orifice (see para. 0054, which states that the cavity in vertebral body 130 receives PMMA 170; see also Figs. 8-10), wherein a portion of the stabilization material remains within the orifice continuous with a mass of the stabilization material in the vertebra to mechanically couple the implantable vertebral interbody device to the vertebra (see Fig. 10) to provide for stabilization of the vertebrae (see paras. 0003-0004) (Fig. 8-10; paras. 0003-0004 and 0054). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Lee by withdrawing the cannula from the one of the vertebrae (claim 21) in order to avoid leaving a sharp surgical instrument that is not in a fixed position relative to the body of the device within the patient after the completion of the surgical procedure. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the method of Lee such that a portion of the stabilization material remains within the at least one orifice continuous with a mass of the stabilization material in the one of the vertebrae to mechanically couple the implantable vertebral interbody device to the one of the vertebrae (claim 21), as suggested by an alternate embodiment of Lee, to provide for stabilization of the vertebrae. Allowable Subject Matter Claims 8 and 23 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Response to Arguments Applicant’s arguments with respect to Wensel have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Applicant's arguments filed October 1, 2026 have been fully considered but they are not persuasive. With regard to Applicant’s Interview Summary (see pg. 8) and Applicant’s remarks regarding Lee (see pg. 10), the Examiner disagrees that the proposed amendments to claims 1 and 21 overcome Lee. As stated in the Interview (see Examiner’s Interview Summary mailed on September 11, 2026), Lee is not overcome as a reference because it can be used in a 103 rejection. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JULIANNA N HARVEY whose telephone number is (571)270-3815. The examiner can normally be reached Mon.-Fri. 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Eduardo Robert can be reached at (571)272-4719. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JULIANNA N HARVEY/Primary Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

May 21, 2024
Application Filed
Jul 02, 2026
Non-Final Rejection mailed — §103, §112
Sep 09, 2026
Applicant Interview (Telephonic)
Sep 09, 2026
Examiner Interview Summary
Oct 01, 2026
Response Filed
Oct 21, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773239
BOTTOM-LOADED PIVOTAL BONE ANCHOR WITH SHANK HEAD COLLET CONTAINMENT
2y 2m to grant Granted Oct 27, 2026
Patent 12751741
ROD FOR SPINAL FIXATION IMPLEMENT AND SPINAL FIXATION IMPLEMENT PROVIDED WITH SAME
3y 2m to grant Granted Oct 06, 2026
Patent 12751744
SURGICAL IMPLANT INSTRUMENTS AND METHODS OF USE
3y 0m to grant Granted Oct 06, 2026
Patent 12746039
AUTOMATED MACHINE LEARNING DESIGN OF ORTHOPEDIC IMPLANTS AND METHODS FOR USING SAME
1y 8m to grant Granted Sep 29, 2026
Patent 12733803
VAGINAL SPECULUM AND CERVICAL SCREENING KIT
3y 10m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
97%
With Interview (+19.1%)
2y 10m (~4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1242 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month